Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John K Forrest

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 17, 2021
Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy RegistryGuilherme F Attizzani, Luis Augusto P Dallan, John K Forrest, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 23, 2024
Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk TrialDaniel J Blackman, Anne M Ryschon, Sophie Barnett, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve DiseaseYousif Ahmad, Vratika Agarwal, Matthew L Williams, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2019
Predictors and Risk Calculator of Early Unplanned Hospital Readmission Following Contemporary Self-Expanding Transcatheter Aortic Valve Replacement from the STS/ACC TVT RegistryCarlos E Sanchez, James B Hermiller, Duane S Pinto, et al.
The American Journal of Cardiology|July 7, 2016
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial)Kimberly A Skelding, Steven J Yakubov, Neal S Kleiman, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 24, 2024
Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trialBasel Ramlawi, G Michael Deeb, Mubashir Mumtaz, et al.
JACC. Cardiovascular Interventions|June 1, 2020
Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT RegistryJohn K Forrest, Ryan K Kaple, Basel Ramlawi, et al.
International Journal of Cardiology|December 8, 2023
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center studyClaudia See, Yanting Wang, Yiping Yang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement: The DEFINE-TAVR Prospective StudyTayyab Shah, Lissa Sugeng, Amit N Vora, et al.
JACC. Cardiovascular Interventions|February 16, 2026
Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench TestingOle de Backer, Ryan Stublaski, Hatem Tadros, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 17, 2021
Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy RegistryGuilherme F Attizzani, Luis Augusto P Dallan, John K Forrest, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 23, 2024
Cost-effectiveness of TAVI in the United Kingdom: a long-term analysis based on 4-year data from the Evolut Low Risk TrialDaniel J Blackman, Anne M Ryschon, Sophie Barnett, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve DiseaseYousif Ahmad, Vratika Agarwal, Matthew L Williams, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2019
Predictors and Risk Calculator of Early Unplanned Hospital Readmission Following Contemporary Self-Expanding Transcatheter Aortic Valve Replacement from the STS/ACC TVT RegistryCarlos E Sanchez, James B Hermiller, Duane S Pinto, et al.
The American Journal of Cardiology|July 7, 2016
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial)Kimberly A Skelding, Steven J Yakubov, Neal S Kleiman, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 24, 2024
Four-year outcomes after transcatheter or contemporary surgical aortic valve replacement from the Evolut Low Risk trialBasel Ramlawi, G Michael Deeb, Mubashir Mumtaz, et al.
JACC. Cardiovascular Interventions|June 1, 2020
Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT RegistryJohn K Forrest, Ryan K Kaple, Basel Ramlawi, et al.
International Journal of Cardiology|December 8, 2023
Impact of sex on Transcatheter aortic valve replacement outcomes: Results of a single-center studyClaudia See, Yanting Wang, Yiping Yang, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|May 11, 2026
Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement: The DEFINE-TAVR Prospective StudyTayyab Shah, Lissa Sugeng, Amit N Vora, et al.
JACC. Cardiovascular Interventions|February 16, 2026
Postdilation of Evolut Transcatheter Heart Valves: Insights From Bench TestingOle de Backer, Ryan Stublaski, Hatem Tadros, et al.
Pageof 12